Schedule 13D ownership disclosure

OUTLOOK THERAPEUTICS INC

Security class unavailable · CUSIP: 69012T206

Event date: 2020-06-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
16,000,000
Percent of class
14.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-072924
Form type
SC 13D
Filer
Outlook Therapeutics, Inc.
CIK
CIK 1649989
Filed
Jun 12, 2020
Reporting period
Jun 02, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub